Free On-line Access

SPCI - Sociedade Portuguesa de Cuidados Intensivos

Revista Brasileira de Terapia Intensiva

AMIB - Associação de Medicina Intensiva Brasileira


ISSN: 0103-507X
Online ISSN: 1982-4335

Ícone Fechar

How to Cite


Talizin TB, Tsuda MS, Tanita MT, Kauss IAM, Festti J, Carrilho CMDM, et al. Resposta para: Injúria renal aguda e hipertensão intra-abdominal em paciente queimado em terapia intensiva. Rev Bras Ter Intensiva. 2019;31(3):430-431



2019 2019;31(3):430-431


Reply to: Acute kidney injury and intra-abdominal hypertension in burn patients in intensive care

Resposta para: Injúria renal aguda e hipertensão intra-abdominal em paciente queimado em terapia intensiva

Thalita Bento Talizin1, Meiry Sayuri Tsuda1, Marcos Toshiyuki Tanita1, Ivanil Aparecida Moro Kauss1, Josiane Festti1, Cláudia Maria Dantas de Maio Carrilho1, Cintia Magalhães Carvalho Grion1, Lucienne Tibery Queiroz Cardoso1

1 Universidade Estadual de Londrina - Londrina (PR), Brazil.


The authors would like to express thanks for the comments and the opportunity to clarify the study points published in the Revista Brasileira de Terapia Intensiva(1) about the incorporation of intra-abdominal pressure (IAP) monitoring in clinical practice.

Regarding the investigation of the use of glycopeptides, the authors clarify that this variable was treated as a potential confounding factor for the outcome "acute renal injury", which was explored in the study. This class of antimicrobials is known to be nephrotoxic(2,3) and is widely used in our critically ill adult patients. Thus, this variable was included in the univariate analysis model together with other potentially confounding variables for the same outcome.

Regarding the continuous measurement of IAP using the AbViser(tm) system, which was described in the methods section, the authors agree with the comments because, as written, this description may cause confusion. The AbViser(tm) AutoValve(tm) IAP monitoring device is sterile, noninvasive, and disposable. It is coupled to the urinary catheter interruptedly. With the AbViser(tm), a measurement is obtained in 1 to 3 minutes, and measurements can be performed frequently but not continuously.

Finally, we agree that further studies are needed on the best routine for monitoring IAP in intensive care units, in addition to studies on the most appropriate conduct regarding altered IAP values. Team awareness of the benefits of this measure is valid for guiding treatments that avoid increasing IAP(4) while minimizing organ dysfunction in critically ill patients.


Talizin TB, Tsuda MS, Tanita MT, Kauss IA, Festti J, Carrilho CM, et al. Acute kidney injury and intra-abdominal hypertension in burn patients in intensive care. Rev Bras Ter Intensiva. 2018;30(1):15-20. Link PubMed
Sinha Ray A, Haikal A, Hammoud KA, Yu AS. Vancomycin and the risk of AKI: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2016;11(12):2132-40. Link DOILink PubMed
Cavalcanti AB, Goncalves AR, Almeida CS, Bugano DD, Silva E. Teicoplanin versus vancomycin for proven or suspected infection. Cochrane Database Syst Rev. 2010;(6):CD007022. Link PubMed
Malbrain ML. Is it wise not to think about intraabdominal hypertension in the ICU? Curr Opin Crit Care. 2004;10(2):132-45. Link DOILink PubMed

Submission On-line

Indexed in




Associação de Medicina Intensiva Brasileira - AMIB

Rua Arminda nº 93 - 7º andar - Vila Olímpia - São Paulo, SP, Brasil - Tel./Fax: (55 11) 5089-2642 | e-mail:

GN1 - Systems and Publications